Sleep apnea treatment developer Inspire Medical Systems has invested in two private companies with digital health tech that could better screen people for sleep problems.
Minneapolis-based Inspire Medical is the maker of a minimally-invasive, implantable device that uses neurostimulation to treat obstructive sleep apnea. It made a $10 million minority equity investment in Madison, Wisconsin–based EnsoData, creator of an FDA-approved sleep study analysis platform called EnsoSleep. The EnsoSleep platform integrates with a sleep labs’ existing software and diagnostic devices, using AI to automatically analyze and score sleep studies.
Inspire Medical also provided seed funding to Buffalo, New York–based Ognomy, creator of the Ognamy app that sleep physicians built to shift sleep apnea diagnosis and treatment from the clinic to people’s homes.
Tim Herbert, CEO of Inspire Medical Systems, said the tools created by EnsoData and Ognomy could help clinician…